Literature DB >> 16038052

Ovarian carcinoma in two patients with chronic liver disease.

Mehlika Isildak1, Gulay-Sain Guven, Murat Kekilli, Yavuz Beyazit, Mustafa Erman.   

Abstract

Ascites is a common and debilitating complication of cirrhosis. However, patients with chronic liver disease are not spared from other causes of ascites and physicians should be careful not to miss an underlying malignancy. Ovarian cancer is an insidious disease, which is difficult to diagnose and it ranks first in mortality among all gynecological cancers. Here, we present two cases of patients with chronic liver disease that developed ascites not simply because of cirrhosis but as a manifestation of ovarian cancer. We would like to emphasize that the causes of ascites, other than the liver itself, should not be overlooked in patients with chronic liver disease.

Entities:  

Mesh:

Year:  2005        PMID: 16038052      PMCID: PMC4434680          DOI: 10.3748/wjg.v11.i28.4445

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

Review 1.  Ascites.

Authors:  T B Reynolds
Journal:  Clin Liver Dis       Date:  2000-02       Impact factor: 6.126

2.  Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.

Authors:  J Llach; P Ginès; V Arroyo; A Rimola; L Titó; S Badalamenti; W Jiménez; J Gaya; F Rivera; J Rodés
Journal:  Gastroenterology       Date:  1988-02       Impact factor: 22.682

3.  Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit.

Authors:  John M J Kirwan; Douglas G Tincello; Jonathan J O Herod; Olive Frost; Robert E Kingston
Journal:  BMJ       Date:  2002-01-19

4.  Elevation of CA 125 in patients with benign and malignant ascites.

Authors:  J F Bergmann; J M Bidart; M George; M Beaugrand; V G Levy; C Bohuon
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

5.  The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.

Authors:  B A Runyon; A A Montano; E A Akriviadis; M R Antillon; M A Irving; J G McHutchison
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

Review 6.  How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma.

Authors:  Alper Sevinc; Celalettin Camci; H Mehmet Turk; Suleyman Buyukberber
Journal:  Oncology       Date:  2003       Impact factor: 2.935

Review 7.  The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.

Authors:  Kevin P Moore; Florence Wong; Pere Gines; Mauro Bernardi; Andreas Ochs; Francesco Salerno; Paolo Angeli; Michael Porayko; Richard Moreau; Guadelupe Garcia-Tsao; Wladimiro Jimenez; Ramon Planas; Vicente Arroyo
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

8.  Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.

Authors:  F Salerno; G Borroni; P Moser; S Badalamenti; L Cassarà; A Maggi; M Fusini; B Cesana
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

Review 9.  Screening for ovarian cancer.

Authors:  Cleola Anderiesz; Michael A Quinn
Journal:  Med J Aust       Date:  2003-06-16       Impact factor: 7.738

10.  A 20-year prospective study of cirrhosis.

Authors:  J B Saunders; J R Walters; A P Davies; A Paton
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.